← all works
RETRACTED ARTICLE: TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Post-publication record
OpenAlex flags this work as retracted, but it carries no matching Retraction Watch record in this frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Medical Oncology
- Topic
- Immune cells in cancer
- Field
- Immunology and Microbiology
- Canadian institutions
- Emergent BioSolutions (Canada)
- Funders
- —
- Keywords
- FOXP3Cancer researchCancerImmunologyCancer immunotherapyAgonistImmunotherapyImmunopharmacologyMedicineTumor necrosis factor alphaEffectorDownregulation and upregulationReceptorPharmacologyBiologyInternal medicineImmune system
- Has abstract in OpenAlex
- no